Corrigendum to: Huazhi Rougan Granule Alleviates Liver and Intestinal Damage in Non-Alcoholic Fatty Liver Disease by Regulating miR-122 Expression and TLR4/MyD88/NF-κB Pathway Activation.

In the published version of this article [1], the following issue was identified: there was redundancy in the guideline section. The corrected version of the section is provided below to ensure clarity and accuracy. The original article can be found online at https://www.eurekaselect.com/article/144567 Details of the correction: Original: HUMAN AND ANIMAL RIGHTS This study adheres to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed to report experiments involving live animals and promote ethical research practices. The procedures followed were consistent with the care and use of standards of "Guide for the Care and Use of Laboratory Animals" as specified in the eighth edition. This study adhered to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices. Corrected: HUMAN AND ANIMAL RIGHTS The procedures followed were consistent with the care and use of standards of "Guide for the Care and Use of Laboratory Animals" as specified in the eighth edition. This study adhered to internationally accepted standards for animal research, following the 3Rs principle. The ARRIVE guidelines were employed for reporting experiments involving live animals, promoting ethical research practices. The publisher apologizes for any inconvenience caused.